Stock Events

Stock Events

Qiagen NV 

$34
80
+$0.04+0.12% Tuesday 20:00

Statistics

Day High
34.09
Day Low
33.24
52W High
55.66
52W Low
33.61
Volume
1,464,828
Avg. Volume
-
Mkt Cap
0
P/E Ratio
16.79
Dividend Yield
0.77%
Dividend
0.26

Upcoming

2
JUL
Dividend Ex
Estimated
 
10
JUL
Dividend Payment
Estimated
 
2
JUL 27
Dividend Ex
Estimated
 
9
JUL 27
Dividend Payment
Estimated
 
3
JUL 28
Dividend Ex
Estimated
 

Dividends

0.77%Dividend Yield
Jan 26
$2.41
Jul 25
$0.26
Jul 25
$0.26
Jan 25
$1.33
Jan 24
$1.35
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
-49.99%

Earnings

23JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.5
0.55
0.6
0.64
Expected EPS
0.607201
Actual EPS
N/A

Financials

19.93%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
6.75BRevenue
1.34BNet Income

Analyst Ratings

47.17Average Price Target
The highest estimate is 60.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QGEN. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap20.63B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with Qiagen's sample and assay technologies.
Thermo Fisher Scientific
TMO
Mkt Cap174.37B
Thermo Fisher Scientific offers a broad range of reagents, instruments, and consumables used in biological and medical research, competing with Qiagen in multiple areas including sample preparation and diagnostics.
Bio-Rad Laboratories
BIO
Mkt Cap6.93B
Bio-Rad Laboratories offers products and systems used to separate complex chemical and biological materials, directly competing with Qiagen in the life sciences research market.
Agilent Technologies
A
Mkt Cap32.36B
Agilent Technologies provides instruments, services, consumables, applications, and expertise, focusing on the life sciences, diagnostics, and applied chemical markets, competing with Qiagen in diagnostics and research.
Pacific Biosciences of California
PACB
Mkt Cap496.78M
Pacific Biosciences offers sequencing systems that compete with Qiagen's genomic and DNA sequencing solutions.
Repligen
RGEN
Mkt Cap6.67B
Repligen Corporation provides bioprocessing technologies and systems that compete with Qiagen's solutions for the purification and isolation of biological samples and substances.
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Bio-Rad Laboratories, through its Class B shares, competes in the same space as its Class A shares, offering similar products and technologies that rival Qiagen's offerings.
Hologic
HOLX
Mkt Cap16.97B
Hologic specializes in diagnostics, medical imaging systems, and surgical products, competing with Qiagen in the diagnostics and women's health market.
Quest Diagnostics
DGX
Mkt Cap21.33B
Quest Diagnostics provides diagnostic testing, information, and services, competing with Qiagen in the diagnostics and molecular diagnostics markets.
Guardant Health
GH
Mkt Cap11.61B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing with Qiagen in the precision medicine and cancer diagnostics space.

About

There is no Profile data available for QIA.SG.
Show more...
CEO
Mr. Thierry L. Bernard
Employees
5700
Country
Netherlands
ISIN
NL0015002SN0

Listings

F
DE
QIA.F
STU
DE
QIA.STU
MU
DE
QIA.MU
XNYS
US
QGEN

0 Comments

Share your thoughts

FAQ

What is Qiagen NV stock price today?▼
The current price of QGEN is $34 USD — it has increased by +0.12% in the past 24 hours. Watch Qiagen NV stock price performance more closely on the chart.
What is Qiagen NV stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Qiagen NV stocks are traded under the ticker QGEN.
Is Qiagen NV stock price growing?▼
QGEN stock has risen by +1.16% compared to the previous week, the month change is a -16.63% fall, over the last year Qiagen NV has showed a -23.41% decrease.
When is the next Qiagen NV earnings date?▼
Qiagen NV is going to release the next earnings report on July 23, 2026.
What were Qiagen NV earnings last quarter?▼
QGEN earnings for the last quarter are 0.54 USD per share, whereas the estimation was 0.54 USD resulting in a -0.28% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Qiagen NV revenue for the last year?▼
Qiagen NV revenue for the last year amounts to 6.75B USD.
What is Qiagen NV net income for the last year?▼
QGEN net income for the last year is 1.34B USD.
Does Qiagen NV pay dividends?▼
Yes, QGEN dividends are paid annual. The last dividend per share was 2.41 USD. As of today, Dividend Yield (FWD)% is 0.77%.
How many employees does Qiagen NV have?▼
As of May 06, 2026, the company has 5,700 employees.
In which sector is Qiagen NV located?▼
Qiagen NV operates in the Health & Wellness sector.
When did Qiagen NV complete a stock split?▼
The last stock split for Qiagen NV was on January 08, 2026 with a ratio of 19:20.
Where is Qiagen NV headquartered?▼
Qiagen NV is headquartered in Venlo, Netherlands.